Literature DB >> 25967380

Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.

Sung K Kim1, Gregory Hannum1, Jennifer Geis1, John Tynan1, Grant Hogg1, Chen Zhao1, Taylor J Jensen1, Amin R Mazloom1, Paul Oeth1, Mathias Ehrich1, Dirk van den Boom1, Cosmin Deciu1.   

Abstract

OBJECTIVE: This study introduces a novel method, referred to as SeqFF, for estimating the fetal DNA fraction in the plasma of pregnant women and to infer the underlying mechanism that allows for such statistical modeling.
METHODS: Autosomal regional read counts from whole-genome massively parallel single-end sequencing of circulating cell-free DNA (ccfDNA) from the plasma of 25 312 pregnant women were used to train a multivariate model. The pretrained model was then applied to 505 pregnant samples to assess the performance of SeqFF against known methodologies for fetal DNA fraction calculations.
RESULTS: Pearson's correlation between chromosome Y and SeqFF for pregnancies with male fetuses from two independent cohorts ranged from 0.932 to 0.938. Comparison between a single-nucleotide polymorphism-based approach and SeqFF yielded a Pearson's correlation of 0.921. Paired-end sequencing suggests that shorter ccfDNA, that is, less than 150 bp in length, is nonuniformly distributed across the genome. Regions exhibiting an increased proportion of short ccfDNA, which are more likely of fetal origin, tend to provide more information in the SeqFF calculations.
CONCLUSION: SeqFF is a robust and direct method to determine fetal DNA fraction. Furthermore, the method is applicable to both male and female pregnancies and can greatly improve the accuracy of noninvasive prenatal testing for fetal copy number variation.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25967380     DOI: 10.1002/pd.4615

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  63 in total

1.  WisecondorX: improved copy number detection for routine shallow whole-genome sequencing.

Authors:  Lennart Raman; Annelies Dheedene; Matthias De Smet; Jo Van Dorpe; Björn Menten
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

2.  Fetal fraction evaluation in non-invasive prenatal screening (NIPS).

Authors:  Matthew S Hestand; Mark Bessem; Peter van Rijn; Renee X de Menezes; Daoud Sie; Ingrid Bakker; Elles M J Boon; Erik A Sistermans; Marjan M Weiss
Journal:  Eur J Hum Genet       Date:  2018-09-25       Impact factor: 4.246

3.  Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy.

Authors:  Nobuhiro Suzumori; Takeshi Ebara; Takahiro Yamada; Osamu Samura; Junko Yotsumoto; Miyuki Nishiyama; Kiyonori Miura; Hideaki Sawai; Jun Murotsuki; Michihiro Kitagawa; Yoshimasa Kamei; Hideaki Masuzaki; Fumiki Hirahara; Juan-Sebastian Saldivar; Nilesh Dharajiya; Haruhiko Sago; Akihiko Sekizawa
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

4.  Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.

Authors:  Jaime L Lopes; Guilherme S Lopes; Elizabeth A L Enninga; Hutton M Kearney; Nicole L Hoppman; Ross A Rowsey
Journal:  Prenat Diagn       Date:  2020-04-20       Impact factor: 3.050

Review 5.  Calculation of Fetal Fraction for Non-Invasive Prenatal Testing.

Authors:  Matthew Cserhati
Journal:  BioTech (Basel)       Date:  2021-08-09

6.  Low Fetal Fraction of Cell Free DNA at Non-Invasive Prenatal Screening Increases the Subsequent Risk of Preterm Birth in Uncomplicated Singleton Pregnancy.

Authors:  Xiaosong Yuan; Xiaoya Han; Chenbo Jia; Wenbo Zhou; Bin Yu
Journal:  Int J Womens Health       Date:  2022-07-13

7.  Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome.

Authors:  Karin Huijsdens-van Amsterdam; Lieve Page-Christiaens; Nicola Flowers; Michael D Bonifacio; Katie M Battese Ellis; Ida Vogel; Else Marie Vestergaard; Javier Miguelez; Mario Henrique Burlacchini de Carvalho; Erik A Sistermans; Mark D Pertile
Journal:  Eur J Hum Genet       Date:  2018-06-13       Impact factor: 4.246

8.  Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.

Authors:  Mathias Ehrich; John Tynan; Amin Mazloom; Eyad Almasri; Ron McCullough; Theresa Boomer; Daniel Grosu; Jason Chibuk
Journal:  Genet Med       Date:  2017-06-15       Impact factor: 8.822

9.  NiPTUNE: an automated pipeline for noninvasive prenatal testing in an accurate, integrative and flexible framework.

Authors:  Véronique Duboc; David Pratella; Marco Milanesio; John Boudjarane; Stéphane Descombes; Véronique Paquis-Flucklinger; Silvia Bottini
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

10.  Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.

Authors:  Annelies Dheedene; Tom Sante; Matthias De Smet; Jean-François Vanbellinghen; Bernard Grisart; Sarah Vergult; Sandra Janssens; Björn Menten
Journal:  Prenat Diagn       Date:  2016-07-01       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.